Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Molecular Subtyping to Predict Risk of Venous Thromboembolism in Patients with Advanced Lung Adenocarcinoma: A Cohort Study

Lorenzo Gervaso, MD, Shyam K Poudel, MD, Joanna Roopkumar, MBBS, MPH, Chandana A Reddy, MS, Nathan A Pennell, MD PhD, Vamsidhar Velcheti, MD, Keith R McCrae, MD, Alok A Khorana, MD

Blood (2019) 134 (Supplement_1): 3651.

https://doi.org/10.1182/blood-2019-128189

Published: 2019

Journal Articles

PET-Directed Therapy for Patients with Limited-Stage Diffuse Large B-Cell Lymphoma - Results of Intergroup Nctn Study S1001

Daniel O. Persky, MD, Hongli Li, MS, Deborah M. Stephens, DO, Steven I Park, MD, Nancy L. Bartlett, MD, Lode J. Swinnen, MB ChB, Paul M. Barr, MD, Jerome D. Winegarden, III, MD, Louis S. Constine, MD, Thomas J. Fitzgerald, MD, John P. Leonard, MD, Brad S. Kahl, MD, Michael L. Leblanc, PhD, Joo Y. Song, MD, Richard I. Fisher, MD, Lisa M. Rimsza, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD

Blood (2019) 134 (Supplement_1): 349.

https://doi.org/10.1182/blood-2019-123871

Published: 2019

Journal Articles

Therapeutic Targeting of an RNA Splicing Factor Network for the Treatment of Myeloid Neoplasms

Sydney X. Lu, MD PhD, Eric Wang, Alessandro Pastore, Chen Xufeng, PhD, Jochen Imig, PhD, Stanley C Lee, PhD, Yohana Ghebrechristos, Akihide Yoshimi, MD, Lillian E Bitner, BSc, Michelle Ki, BSc, Andreas Kloetgen, Kuan-Ting Lin, PhD, Raoul Tibes, MD PhD, Adrian R. Krainer, PhD, Taisuke Uehara, Takashi Owa, PhD, Iannis Aifantis, PhD, Omar I Abdel-Wahab, MD

Blood (2018) 132 (Supplement 1): 427.

https://doi.org/10.1182/blood-2018-99-111430

Published: 2018

Journal Articles

Comprehensive Multi-Omics Analysis of Gene Fusions in a Large Multiple Myeloma Cohort

Steven M. Foltz, MS, Qingsong Gao, PhD, Christopher J. Yoon, MPhil, Amila Weerasinghe, PhD, Hua Sun, PhD, Lijun Yao, MS, Mark A. Fiala, BS, Daniel R. Kohnen, MBA, Justin King, BS, Yeong Seok Ju, MD PhD, John F. DiPersio, MD PhD, Ravi Vij, MBBS, Li Ding, PhD

Blood (2018) 132 (Supplement 1): 1898.

https://doi.org/10.1182/blood-2018-99-117245

Published: 2018

Journal Articles

Biological Characterization of the U2af1 S34F Mutation in the Pathogenesis of Myelodysplasia

Ayana Kon, MD PhD, Yasuhito Nannya, MD PhD, Masahiro Nakagawa, MD PhD, Keisuke Kataoka, MD PhD, Masashi Sanada, MD PhD, Manabu Nakayama, PhD, Haruhiko Koseki, PhD, Seishi Ogawa, MD PhD

Blood (2018) 132 (Supplement 1): 3080.

https://doi.org/10.1182/blood-2018-99-117453

Published: 2018

Journal Articles

Inhibiting Aurora Kinase B Sensitizes B-Cell Acute Lymphoblastic Leukemia to Glucocorticoids

Coralie Poulard, Hye Na Kim, Celine Gagnieux, Karina Kruth, PhD, Mimi Fang, Daniel Gerke, Deepa Bhojwani, MD, Yong-Mi Kim, MD MPH, PhD, Michael R Stallcup, PhD, Miles A. Pufall, PhD

Blood (2017) 130 (Supplement 1): 5113.

https://doi.org/10.1182/blood.V130.Suppl_1.5113.5113

Published: 2017

Journal Articles

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer Associated Thrombosis. the Observational Roadmap-CAT Study

Grigorios T. Gerotziafas, MD PhD, Patrick Van Dreden, PhD, Stella Salta, Loula Papageorgiou, Paraskevi Boura, Annette Larsen, Jawed Fareed, PhD, Konstantinos Syrigos, Ismail Elalamy, MD PhD

Blood (2017) 130 (Supplement 1): 2381.

https://doi.org/10.1182/blood.V130.Suppl_1.2381.2381

Published: 2017

Journal Articles

Targeting the MALAT1/PARP1/LIG3 Complex Induces DNA Damage and Apoptosis in Multiple Myeloma Mouse Models

Yi Hu, Jing Fang, Hua Fang, Chen Li, Shuang Liu, Sarah L. Ondrejka, MD, Zihua Gong, Jaroslaw P. Maciejewski, PhD MD FACP, Frederic J. Reu, MD, Qing Yi, MD PhD, Jianjun Zhao, MD

Blood (2017) 130 (Supplement 1): 1829.

https://doi.org/10.1182/blood.V130.Suppl_1.1829.1829

Published: 2017

Journal Articles

Single-Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia Who Are Either Hydroxyurea-Resistant or Intolerant: Final Results of the Myeloproliferative Disorders-Research Consortium (MPD-RC) Protocol 111 Global Phase II Trial

Blood (2017) 130 (Supplement 1): 321.

https://doi.org/10.1182/blood.V130.Suppl_1.321.321

Published: 2017

Journal Articles

Ibrutinib Combined with Rituximab in Treatment-Naive Patients with Follicular Lymphoma: Arm 1 + Arm 2 Results from a Multicenter, Open-Label Phase 2 Study

Nathan Fowler, MD, Loretta Nastoupil, MD, Sven de Vos, MD PhD, Mark Knapp, MD, Ian W. Flinn, MD PhD, Robert W Chen, MD, Ranjana H Advani, MD, Sumeet Bhatia, MD, Peter Martin, MD, Raul Mena, MD, Samuel Suzuki, MS, MBA, Darrin M. Beaupre, MD PhD, Jutta K. Neuenburg, MD PhD, M. Lia Palomba, MD

Blood (2016) 128 (22): 1804.

https://doi.org/10.1182/blood.V128.22.1804.1804

Published: 2016

Journal Articles

Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada

Katie Y. Zhu, BHSc, Kevin W. Song, MD, Joseph M Connors, MD, Tracy Tucker, PhD FCCMG, Graham W. Slack, MD, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, FRCPC, FRCP, FRCPath, Donna L. Forrest, MD FRCPC, Donna E. Hogge, MD PhD, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Thomas J. Nevill, MD FRCPC, Maryse M Power, MB, MRCPI, FRCPath, David Sanford, MD FRCPC, Cynthia L. Toze, MD MHSc, FRCPC, Heather J. Sutherland, MD PhD FRCPC, Laurie H. Sehn, Raewyn Broady, MBChB, FRACP, Alina S. Gerrie, MD MPH, FRCPC

Blood (2016) 128 (22): 1113.

https://doi.org/10.1182/blood.V128.22.1113.1113

Published: 2016

Journal Articles

Evaluation of Efficacy and Safety of Direct Oral Anticoagulants (DOACS) in the Treatment of Venous Thromboembolism in Cancer Patients

Ali McBride, PharmD,MS, Reem Diri, PharmD, Chris Campen, PharmD, Ivo Abraham, PhD RN

Blood (2016) 128 (22): 5016.

https://doi.org/10.1182/blood.V128.22.5016.5016

Published: 2016

Journal Articles

Venetoclax Combined with Bortezomib and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

Philippe Moreau, Asher A. Chanan-Khan, MD, Andrew W. Roberts, Amit B. Agarwal, Thierry Facon, MD, Shaji Kumar, MD, Cyrille Touzeau, Jaclyn Cordero, Jeremy Ross, Wijith Munasinghe, Jia Jia, Ahmed H. Salem, Joel Leverson, Paulo Maciag, Maria Verdugo, Simon J. Harrison

Blood (2016) 128 (22): 975.

https://doi.org/10.1182/blood.V128.22.975.975

Published: 2016

Journal Articles

Long Non-Coding RNA MALAT1 Is Associated with the Progression of Multiple Myeloma and Induced By Cellular Stress

Blood (2015) 126 (23): 1759.

https://doi.org/10.1182/blood.V126.23.1759.1759

Published: 2015

Journal Articles

Everolimus in Combination with Crizotinib Synergistically Inhibits the Growth of ALK-Positive Anaplastic Large Cell Lymphoma Cells

Wendan Xu, MS, Ji-Won Kim, MD MS, Junglim Lee, MD, Hyo Jung Kim, MD PhD, Hwi-Joong Yoon, MD PhD, Sung-Soo Yoon, MD PhD

Blood (2014) 124 (21): 4488.

https://doi.org/10.1182/blood.V124.21.4488.4488

Published: 2014

Journal Articles

Differential Influence of Lung Cancer Stage, Time from Diagnosis and Chemotherapy on Plasma and Cellular Biomarkers of Hypercoagulability. the Roadmap Study

Ilias Evmorfiadis, Paraskevi Boura, Aurélie Rousseau, Ariadni Charpidou, Giannis Giozos, Patrick Van Dreden, PhD, Konstantinos Syrigos, Anastasia Spanoudaki, Matthieu Grusse, Ismail Elalamy, MD, Grigorios T. Gerotziafas, Dr

Blood (2014) 124 (21): 4253.

https://doi.org/10.1182/blood.V124.21.4253.4253

Published: 2014

Journal Articles

Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects

Timothy Geoffrey Bowler, PhD MBBS, Matthias Bartenstein, MD, Kerry A. Morrone, MD, Mersedeh Rohanizadegan, MD, Rachel M. Kessel, MD, Lauren Hooda, Ishan Datt, Orsolya Giricz, PhD, Tushar D. Bhagat, PhD, Bartlomiej P Przychodzen, Simrit Parmar, Jonathan B. Gill, MD, Yiting Yu, PhD, Jaroslaw P. Maciejewski, MD PhD, Ulrich Steidl, MDPhD, Amit Verma, MD

Blood (2014) 124 (21): 4591.

https://doi.org/10.1182/blood.V124.21.4591.4591

Published: 2014

Journal Articles

MLAA-34: A New Leukemia-Associated Antigen for Immunotherapy Against Acute Monocytic Leukemia

Ju Bai, Aili He, Wanggang Zhang, Jianli Wang, Yun Yang, Pengyu Zhang, Liufang Gu, Jin Wang, Yang Zhang, Lei Zhang, Rui Shi, Xiaman Wang, Xiaoru Lei

Blood (2014) 124 (21): 5298.

https://doi.org/10.1182/blood.V124.21.5298.5298

Published: 2014

Journal Articles

Validation of Digital-PCR Analysis through Programmed imatinib Interruption in Q-RT-PCR Negative Chronic Myeloid Leukemia Patients

Blood (2013) 122 (21): 4040.

https://doi.org/10.1182/blood.V122.21.4040.4040

Published: 2013

Journal Articles

Co-Treatment Of Hairy Cell Leukemia and Melanoma With The BRAF Inhibitor Dabrafenib

Leslie A. Andritsos, MD, James S. Blachly, MD, Kari Kendra, M.D., Gerard Lozanski, M.D., Michael R. Grever, MD

Blood (2013) 122 (21): 5311.

https://doi.org/10.1182/blood.V122.21.5311.5311

Published: 2013

NARROW

Molecular Subtyping to Predict Risk of Venous Thromboembolism in Patients with Advanced Lung Adenocarcinoma: A Cohort Study

PET-Directed Therapy for Patients with Limited-Stage Diffuse Large B-Cell Lymphoma - Results of Intergroup Nctn Study S1001

Therapeutic Targeting of an RNA Splicing Factor Network for the Treatment of Myeloid Neoplasms

Comprehensive Multi-Omics Analysis of Gene Fusions in a Large Multiple Myeloma Cohort

Biological Characterization of the U2af1 S34F Mutation in the Pathogenesis of Myelodysplasia

Inhibiting Aurora Kinase B Sensitizes B-Cell Acute Lymphoblastic Leukemia to Glucocorticoids

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer Associated Thrombosis. the Observational Roadmap-CAT Study

Targeting the MALAT1/PARP1/LIG3 Complex Induces DNA Damage and Apoptosis in Multiple Myeloma Mouse Models

Ibrutinib Combined with Rituximab in Treatment-Naive Patients with Follicular Lymphoma: Arm 1 + Arm 2 Results from a Multicenter, Open-Label Phase 2 Study

Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada

Evaluation of Efficacy and Safety of Direct Oral Anticoagulants (DOACS) in the Treatment of Venous Thromboembolism in Cancer Patients

Venetoclax Combined with Bortezomib and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

Long Non-Coding RNA MALAT1 Is Associated with the Progression of Multiple Myeloma and Induced By Cellular Stress

Everolimus in Combination with Crizotinib Synergistically Inhibits the Growth of ALK-Positive Anaplastic Large Cell Lymphoma Cells

Differential Influence of Lung Cancer Stage, Time from Diagnosis and Chemotherapy on Plasma and Cellular Biomarkers of Hypercoagulability. the Roadmap Study

Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects

MLAA-34: A New Leukemia-Associated Antigen for Immunotherapy Against Acute Monocytic Leukemia

Validation of Digital-PCR Analysis through Programmed imatinib Interruption in Q-RT-PCR Negative Chronic Myeloid Leukemia Patients

Co-Treatment Of Hairy Cell Leukemia and Melanoma With The BRAF Inhibitor Dabrafenib

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only